Research suggests that the positioning of immune cells in tumors may be a predictor of overall survival in high-grade serous ovarian cancer. However, it is unclear if this applies to other types of ovarian cancer, such as clear cell ovarian cancer, which may involve different immune cell phenotypes. Studies are exploring the use of artificial intelligence, multi-omics, and other techniques to better understand the tumor microenvironment and improve treatment outcomes for ovarian cancer patients.